Randomised controlled study of oral erythromycin for treatment of gastrointestinal dysmotility in preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 84, Issue 3, 2001, Pages

  Ng, P C ^a   So, K W ^a   Fung, K S C ^a   Lee, C H ^a   Fok, T F ^a   Wong, E ^a   Wong, W ^a   Cheung, K L ^a   Cheng, A F B ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Enteral feeding; Erythromycin; Gastrointestinal dysmotility; Preterm; Randomised controlled trial; Very low birthweight infants

Indexed keywords

ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; PLACEBO;

ARTICLE; CHOLESTASIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIGESTIVE SYSTEM FUNCTION DISORDER; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ENTERIC FEEDING; FEMALE; GASTROINTESTINAL MOTILITY; HEART ARRHYTHMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; PYLORUS STENOSIS; RANDOMIZED CONTROLLED TRIAL; SEPSIS; VERY LOW BIRTH WEIGHT;

EID: 0035014551     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/fn.84.3.f177     Document Type: Article

References (42)

1. Macrolides in roles beyond antibiotic therapy
2. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility
3. Regulation of migrating motor complexes by motilin and pancreatic polypeptide in human infants
4. Erythromycin exerts a prokinetic effect in patients with chronic idiopathic intestinal pseudoobstruction
5. Erythromycin strengthens the hypotensive lower oesophageal sphincter in patients with gastroesophageal reflux disease
6. Erythromycin in neonatal postoperative intestinal dysmotility
7. Improvement of gastric emptying in diabetic gastroparesis by erythromycin
8. Effect of acute and chronic administration of erythromycin on gastrointestinal motility in scleroderma patients
9. Erythromycin improves emptying of the denervated stomach after oesophagectomy
10. Intravenous erythromycin for postpyloric intubation
11. Jejunal biopsy with Watson's capsule and erythromycin
12. Erythromycin as a prokinetic agent: A prospective, randomized, controlled study of efficacy in nasoenteric tube placement
13. Erythromycin treatment for gastrointestinal dysmotility in preterm infants
14. Effect of erythromycin on feeding intolerance in very low birth weight infants: A preliminary observation
15. Erythromycin improves gastrointestinal motility in extremely low birthweight infants
16. Erythromycin increases gastric antral motility in human premature infants
17. Double blind, randomised, placebo controlled study of oral vancomycin in prevention of necrotising enterocolitis in preterm, very low birth weight infants
18. Cardiac toxicity associated with intravenous erythromycin lactobionate: Two case reports and a review of the literature
19. Cardiac toxicity of intravenous erythromycin lactobionate in preterm infants
20. Antimicrobial agents
21. Pharmacokinetics on intravenous erythromycin lactobionate
22. Erythromycin pharmacokinetics in man
23. The use of erythromycin lactobionate to facilitate the postpyloric passage of tubes in children
24. Erythromycin accelerates gastric emptying by inducing antral contractions and improved gastro-duodenal coordination
25. Influence of erythromycin on establishment of feeding in preterm infants: Observations from a randomised controlled trial
26. Randomised trial of erythromycin on the development of chronic lung disease in preterm infants
27. Changes in pyloric resistance induced by erythromycin
28. Involvement of two different pathways in the motor effects of erythromycin on the gastric antrum in humans
29. Gastrokinetic effects of erythromycin: Myogenic and neurogenic mechanisms of action in rabbit stomach
30. Effects of erythromycin in the dog upper gastrointestinal tract
31. Gastrointestinal motor effects of erythromycin
32. Effect of erythromycin on gastric motility in controls and in diabetic gastroparesis
33. Erythromycin enhances fasting and postprandial proximal gastric tone in humans
34. Intravenous erythromycin overcomes small intestinal feedback on antral, pyloric, and duodenal motility
35. Ontogeny of fasting small intestinal motor activity in the human infant
36. Gestational evolution of small intestinal motility in preterm and term infants
37. Postnatal maturation of small intestinal motility in preterm infants and term infants
38. Motilin and the interdigestive motor complex in man
39. Pancreatic polypeptide is not involved in the regulation of the migrating motor complex in man
40. Enteral nutrients promote postnatal maturation of intestinal motor activity
41. Effects of a new motilide, ABT-229, on gastric emptying and postprandial antroduodenal motility in healthy volunteers
42. The effects of ABT-229 and octreotide on interdigestive small bowel motility, bacterial overgrowth and bacterial translocation in rats